Patents by Inventor Jeremy E. Turnbull

Jeremy E. Turnbull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11186603
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical and cosmeceutical compositions containing the compounds, and methods of treating cancer, inflammation, diabetic nephropathy, neurodegenerative disorders, Niemann-Pick Type C disease, or dermatological conditions.
    Type: Grant
    Filed: March 23, 2017
    Date of Patent: November 30, 2021
    Assignees: VICTORIA LINK LIMITED
    Inventors: Jeremy E. Turnbull, Andrew Munkacsi, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Publication number: 20200131217
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical and cosmeceutical compositions containing the compounds, and methods of treating cancer, inflammation, diabetic nephropathy, neurodegenerative disorders, Niemann-Pick Type C disease, or dermatological conditions.
    Type: Application
    Filed: March 23, 2017
    Publication date: April 30, 2020
    Inventors: Jeremy E. TURNBULL, Andrew MUNKACSI, Peter Charles TYLER, Olga Vladimirovna ZUBKOVA
  • Patent number: 9879041
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Grant
    Filed: November 28, 2013
    Date of Patent: January 30, 2018
    Assignees: Victoria Link Limited, University of Liverpool
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova, Jeremy E. Turnbull
  • Publication number: 20170152279
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: November 28, 2013
    Publication date: June 1, 2017
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova, Jeremy E. Turnbull
  • Publication number: 20160185881
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: March 7, 2016
    Publication date: June 30, 2016
    Inventors: Ralf Schwörer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Patent number: 9315587
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: April 19, 2016
    Assignees: Victoria Link Limited, The University of Liverpool
    Inventors: Ralf Schwoerer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Publication number: 20150291644
    Abstract: The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: November 28, 2013
    Publication date: October 15, 2015
    Inventors: Peter Charles Tyler, Olga Vladimirovna Zubkova, Jeremy E. Turnbull
  • Publication number: 20140051659
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: March 9, 2012
    Publication date: February 20, 2014
    Applicants: The University of Liverpool, Callaghan Innovation Research Limited
    Inventors: Ralf Schwoerer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova